|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 270, Issue 3 630-R635, Copyright © 1996 by American Physiological Society
ARTICLES |
N. Parekh, L. Dobrowolski, A. P. Zou and M. Steinhausen
Department of Physiology, University of Heidelberg, Germany.
This study compared the vasoconstrictor action of angiotensin II (ANG II) and norepinephrine (NE) with different levels of nitric oxide (NO) in the kidney of anesthetized rats. In one series of experiments, the drugs were infused intravenously, and systemic NO content was reduced by a NO synthase inhibitor, nitro-L-arginine methyl ester (L-NAME). L-NAME significantly enhanced the renal blood flow (RBF) reduction produced by ANG II from 26 to 49%, but it had no significant effect on the change in RBF induced by NE. Medullary blood flow was not influenced by either ANG II or NE given alone or given after L-NAME. In the second series of experiments, all drugs were infused into the renal artery to avoid their systemic and, hence, extrarenal effects. In these experiments, renal content of NO was increased by the NO donor sodium nitroprusside (SNP), decreased by L-NAME, or restored by replacing endogenous NO by exogenous NO (L-NAME + SNP). Effects of both ANG II and NE on RBF were similarly and significantly attenuated by SNP (60% of control), enhanced by L-NAME (200% of control), and restored by L-NAME + SNP (90% of control, not significant). Our results indicate that NO attenuates the renal vasoconstriction due to ANG II or NE and that the antagonism between vasoconstrictors and NO is not due to a constrictor-induced production of NO because exogenous and endogenous NO were equally effective.
This article has been cited by other articles:
![]() |
P. M. O'Connor, M. M. Kett, W. P. Anderson, and R. G. Evans Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow Am J Physiol Renal Physiol, March 1, 2006; 290(3): F688 - F694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Rajapakse, R. J. Roman, J. R. Falck, J. J. Oliver, and R. G. Evans Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R181 - R187. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Fortepiani, M. C. O. Ruiz, F. Passardi, M. D. Bentley, J. Garcia-Estan, E. L. Ritman, and J. C. Romero Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT Am J Physiol Renal Physiol, November 1, 2003; 285(5): F852 - F860. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkis, K. L. Liu, M. Lo, and D. Benzoni Angiotensin II and renal medullary blood flow in Lyon rats Am J Physiol Renal Physiol, February 1, 2003; 284(2): F365 - F372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. PATZAK, R. MROWKA, E. STORCH, B. HOCHER, and P. B. PERSSON Interaction of Angiotensin II and Nitric Oxide in Isolated Perfused Afferent Arterioles of Mice J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1122 - 1127. [Abstract] [Full Text] |
||||
![]() |
S. A. W. Dukacz, M.-G. Feng, L.-F. Yang, R. M. K. W. Lee, and R. L. Kline Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1076 - R1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Schoonmaker, R. W. Fallet, and P. K. Carmines Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus Am J Physiol Renal Physiol, February 1, 2000; 278(2): F302 - F309. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Symons, C. L. Stebbins, and T. I. Musch Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats J Appl Physiol, August 1, 1999; 87(2): 574 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bauer, C. Dau, A. Cavarape, F. Schaefer, H. Ehmke, and N. Parekh ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H1 - H7. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Nowicki Effects of sustained low-flow perfusion on the response to vasoconstrictor agents in postnatal intestine Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1408 - G1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Ortiz, L. A. Fortepiani, F. M. Ruiz-Marcos, N. M. Atucha, and J. Garcia-Estan Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R760 - R766. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |